The global drug industry has fought to prevent developing nations from making low-cost, generic versions of drugs under patent, but the demand for such alternatives is could rise with increasing ...

Forbes contributors publish independent expert analyses and insights. The U.S. spent $722.5 billion on pharmaceuticals in 2023. Although brand-name drugs consume four out of every 5 dollars America ...

Discover what generic brands are, how they differ from store brands, and explore their types, including food and ...

The post Senate Leaders Warn Defense Department About Procuring Generic Drugs Overseas appeared first on ProPublica.

Generic drugmakers face pricing pressure, but companies like TEVA, SDZNY and RDY are betting on complex generics and biosimilars to protect growth.

Investigation raises concerns about lack of FDA quality testing for generic drugs By some estimates, about 90% of prescriptions in the U.S. are filled with generic drugs. The Food and Drug ...

Generic drugmakers and hospital pharmacists warn that added financial pressure from tariffs could strain the nation's generic drug supplies.

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. These highlights were written by the reporters and editors ...

AIOCD directive comes at a time when semaglutide, one of the global blockbuster GLP-1 drug sold by Danish drug major Novo Nordisk under brand names such as Ozempic and Wegovy, is going off patent in ...